Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies

Their correlation with steroid receptors

S. Marsigliante, L. Biscozzo, M. Correale, A. Paradiso, G. Leo, I. Abbate, C. D. Dragone, C. Storelli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Commercially available immunoradiometric assays were used for pS2 and total cathepsin D determination in the cytosol fraction obtained from 266 primary breast cancers. We show that pS2 and cathepsin D values were significantly associated (Spearman's rank correlation: P <0.0001) in tumours from lymph node-positive patients (N+), while such association did not reach significance in tumours taken from patients with negative lymph nodes (N-). Moreover, cathepsin D concentrations in pS2-rich tumours (pS2 above the median value, 5 ng mg-1 protein) were significantly higher (Mann-Whitney-Wilcoxon's rank-sum test: P = 0.00001) than those obtained in the samples expressing less than 5 ng of pS2 per mg of protein. pS2 was also correlated to both the oestrogen receptor (ER) (Spearman's rank correlation: P <0.0001) and the progesterone receptor (PR) (Spearman's rank correlation: P = 0.022). No significant differences in the expression of pS2 and cathepsin D taken from N+ and N- patients were found. Furthermore, no significant differences in pS2 and cathepsin D expression were obtained by stratifying tumours on the basis of their size (T). pS2 and cathepsin D values obtained in ER-positive/PR-positive tumours did not significantly differ from the values obtained in ER-positive/PR-negative and in ER-negative/PR-positive tumours. We conclude that pS2 could have a role in cathepsin D expression, and that it can be used in the assessment of a functioning oestrogen response machinery in those tumours that express only ER.

Original languageEnglish
Pages (from-to)550-554
Number of pages5
JournalBritish Journal of Cancer
Volume69
Issue number3
Publication statusPublished - 1994

Fingerprint

Cathepsin D
Steroid Receptors
Breast Neoplasms
Biopsy
Progesterone Receptors
Neoplasms
Nonparametric Statistics
Lymph Nodes
Immunoradiometric Assay
Estrogen Receptors
Cytosol
Estrogens
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies : Their correlation with steroid receptors. / Marsigliante, S.; Biscozzo, L.; Correale, M.; Paradiso, A.; Leo, G.; Abbate, I.; Dragone, C. D.; Storelli, C.

In: British Journal of Cancer, Vol. 69, No. 3, 1994, p. 550-554.

Research output: Contribution to journalArticle

Marsigliante, S. ; Biscozzo, L. ; Correale, M. ; Paradiso, A. ; Leo, G. ; Abbate, I. ; Dragone, C. D. ; Storelli, C. / Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies : Their correlation with steroid receptors. In: British Journal of Cancer. 1994 ; Vol. 69, No. 3. pp. 550-554.
@article{612ce9b421bf4839b5dd4e8e4143697d,
title = "Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: Their correlation with steroid receptors",
abstract = "Commercially available immunoradiometric assays were used for pS2 and total cathepsin D determination in the cytosol fraction obtained from 266 primary breast cancers. We show that pS2 and cathepsin D values were significantly associated (Spearman's rank correlation: P <0.0001) in tumours from lymph node-positive patients (N+), while such association did not reach significance in tumours taken from patients with negative lymph nodes (N-). Moreover, cathepsin D concentrations in pS2-rich tumours (pS2 above the median value, 5 ng mg-1 protein) were significantly higher (Mann-Whitney-Wilcoxon's rank-sum test: P = 0.00001) than those obtained in the samples expressing less than 5 ng of pS2 per mg of protein. pS2 was also correlated to both the oestrogen receptor (ER) (Spearman's rank correlation: P <0.0001) and the progesterone receptor (PR) (Spearman's rank correlation: P = 0.022). No significant differences in the expression of pS2 and cathepsin D taken from N+ and N- patients were found. Furthermore, no significant differences in pS2 and cathepsin D expression were obtained by stratifying tumours on the basis of their size (T). pS2 and cathepsin D values obtained in ER-positive/PR-positive tumours did not significantly differ from the values obtained in ER-positive/PR-negative and in ER-negative/PR-positive tumours. We conclude that pS2 could have a role in cathepsin D expression, and that it can be used in the assessment of a functioning oestrogen response machinery in those tumours that express only ER.",
author = "S. Marsigliante and L. Biscozzo and M. Correale and A. Paradiso and G. Leo and I. Abbate and Dragone, {C. D.} and C. Storelli",
year = "1994",
language = "English",
volume = "69",
pages = "550--554",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies

T2 - Their correlation with steroid receptors

AU - Marsigliante, S.

AU - Biscozzo, L.

AU - Correale, M.

AU - Paradiso, A.

AU - Leo, G.

AU - Abbate, I.

AU - Dragone, C. D.

AU - Storelli, C.

PY - 1994

Y1 - 1994

N2 - Commercially available immunoradiometric assays were used for pS2 and total cathepsin D determination in the cytosol fraction obtained from 266 primary breast cancers. We show that pS2 and cathepsin D values were significantly associated (Spearman's rank correlation: P <0.0001) in tumours from lymph node-positive patients (N+), while such association did not reach significance in tumours taken from patients with negative lymph nodes (N-). Moreover, cathepsin D concentrations in pS2-rich tumours (pS2 above the median value, 5 ng mg-1 protein) were significantly higher (Mann-Whitney-Wilcoxon's rank-sum test: P = 0.00001) than those obtained in the samples expressing less than 5 ng of pS2 per mg of protein. pS2 was also correlated to both the oestrogen receptor (ER) (Spearman's rank correlation: P <0.0001) and the progesterone receptor (PR) (Spearman's rank correlation: P = 0.022). No significant differences in the expression of pS2 and cathepsin D taken from N+ and N- patients were found. Furthermore, no significant differences in pS2 and cathepsin D expression were obtained by stratifying tumours on the basis of their size (T). pS2 and cathepsin D values obtained in ER-positive/PR-positive tumours did not significantly differ from the values obtained in ER-positive/PR-negative and in ER-negative/PR-positive tumours. We conclude that pS2 could have a role in cathepsin D expression, and that it can be used in the assessment of a functioning oestrogen response machinery in those tumours that express only ER.

AB - Commercially available immunoradiometric assays were used for pS2 and total cathepsin D determination in the cytosol fraction obtained from 266 primary breast cancers. We show that pS2 and cathepsin D values were significantly associated (Spearman's rank correlation: P <0.0001) in tumours from lymph node-positive patients (N+), while such association did not reach significance in tumours taken from patients with negative lymph nodes (N-). Moreover, cathepsin D concentrations in pS2-rich tumours (pS2 above the median value, 5 ng mg-1 protein) were significantly higher (Mann-Whitney-Wilcoxon's rank-sum test: P = 0.00001) than those obtained in the samples expressing less than 5 ng of pS2 per mg of protein. pS2 was also correlated to both the oestrogen receptor (ER) (Spearman's rank correlation: P <0.0001) and the progesterone receptor (PR) (Spearman's rank correlation: P = 0.022). No significant differences in the expression of pS2 and cathepsin D taken from N+ and N- patients were found. Furthermore, no significant differences in pS2 and cathepsin D expression were obtained by stratifying tumours on the basis of their size (T). pS2 and cathepsin D values obtained in ER-positive/PR-positive tumours did not significantly differ from the values obtained in ER-positive/PR-negative and in ER-negative/PR-positive tumours. We conclude that pS2 could have a role in cathepsin D expression, and that it can be used in the assessment of a functioning oestrogen response machinery in those tumours that express only ER.

UR - http://www.scopus.com/inward/record.url?scp=0028220263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028220263&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 550

EP - 554

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 3

ER -